Medicare Enrolled
Dr. Penny Vandestreek, D.O.
In Vivo & In Vitro Nuclear Medicine Physician · Roseville, CA
Practice pattern: Cardiac Imaging
— Practice with significant diagnostic imaging and stress testing
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Vandestreek from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vandestreek?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vandestreek
Dr. Penny Vandestreek is an in vivo & in vitro nuclear medicine physician in Roseville, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Vandestreek performed 8,316 Medicare services across 7,072 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vandestreek received a total of $649 from 6 pharmaceutical and/or device companies across 9 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in in vivo & in vitro nuclear medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vandestreek is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 33% volume in CA
$649 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,316
Medicare services
Top 33% in CA for in vivo & in vitro nuclear medicine physician
7,072
Unique beneficiaries
$105
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~438 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
3,706 | $42 | $214 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
1,164 | $44 | $150 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
641 | $76 | $318 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
495 | $11 | $65 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
314 | $385 | $2,149 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
301 | $54 | $311 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
257 | $16 | $87 |
| Technetium Tc-99m medronate diagnostic injection An injection of Technetium Tc-99m medronate used for diagnostic imaging studies. The dose administered is up to 30 millicuries per study. |
145 | $12 | $54 |
| SPECT nuclear medicine scan, 1 area A nuclear medicine imaging test using a single photon emission computed tomography (SPECT) scan to create detailed images of one specific area of the body. |
102 | $320 | $1,809 |
| I-123 ioflupane diagnostic injection A diagnostic injection of I-123 ioflupane used for imaging studies, with a dose up to 5 millicuries. |
98 | $2,174 | $5,479 |
| Lung ventilation and perfusion scan A nuclear medicine test that uses radioactive tracers to evaluate both air flow (ventilation) and blood flow (perfusion) in the lungs. |
97 | $41 | $264 |
| SPECT/CT scan, single area A nuclear medicine imaging study that combines single-photon emission computed tomography (SPECT) with a concurrent CT scan to create detailed images of a single body area. |
86 | $394 | $1,880 |
| Whole body bone and joint nuclear medicine scan A nuclear medicine imaging test that uses a radioactive tracer to create pictures of the entire skeleton and joints. This scan helps evaluate bone health and detect abnormalities throughout the body. |
84 | $241 | $1,365 |
| Nuclear medicine liver and bile duct scan A nuclear medicine imaging test to evaluate the liver and bile duct system. |
73 | $28 | $180 |
| Injection, furosemide, up to 20 mg | 59 | $0 | $5 |
| SPECT/CT nuclear medicine scan, multiple areas A combined nuclear medicine and CT imaging study performed on at least two body areas or through separate acquisitions on the same day. |
57 | $737 | $3,488 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
54 | $58 | $290 |
| Parathyroid nuclear medicine study with SPECT/CT A nuclear medicine imaging test that uses a radioactive tracer to visualize the parathyroid glands, combined with SPECT and CT scans for detailed anatomical localization. |
43 | $345 | $2,143 |
| Bone density scan (DEXA) of forearm, finger, hand, or foot A DEXA scan measures bone mineral density in the forearm, finger, hand, or foot. This test helps assess bone strength and risk of fracture. |
36 | $35 | $149 |
| Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 36 | $51 | $146 |
| Nuclear medicine lung circulation study A nuclear medicine test that uses a small amount of radioactive material to create images of blood flow through the lungs. |
33 | $26 | $175 |
| Technetium Tc-99m sulfur colloid diagnostic injection A diagnostic injection of Technetium Tc-99m sulfur colloid used for imaging studies. The dose administered is up to 20 millicuries per study. |
33 | $134 | $171 |
| Technetium Tc-99m red blood cell scan A diagnostic nuclear medicine imaging study using Technetium Tc-99m labeled red blood cells to visualize blood flow or detect bleeding. |
33 | $85 | $296 |
| Nuclear medicine heart pumping function test A nuclear medicine study that labels red blood cells to measure the volume of blood ejected from the heart with each beat over multiple cycles. |
32 | $189 | $1,202 |
| Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | 31 | $708 | $1,629 |
| Nuclear medicine stomach emptying study A nuclear medicine test used to assess how quickly the stomach empties its contents. |
30 | $270 | $1,561 |
| Nuclear medicine kidney study with drug administration A nuclear medicine test that evaluates kidney blood flow and function using a radioactive tracer and drug administration. |
30 | $154 | $907 |
| Injection, sincalide, 5 micrograms | 30 | $66 | $84 |
| Injection of radioactive material for lymph node identification A radioactive substance is injected to help locate lymph nodes during imaging procedures. |
29 | $75 | $174 |
| Nuclear medicine liver and bile duct study with drugs A nuclear medicine imaging test to examine the liver and bile duct system using administered drugs. |
29 | $361 | $1,946 |
| Technetium Tc-99m tilmanocept diagnostic injection A diagnostic injection of Technetium Tc-99m tilmanocept used for imaging, with a dosage of up to 0.5 millicuries. |
28 | $428 | $564 |
| Technetium Tc-99m pyrophosphate diagnostic injection A diagnostic injection of Technetium Tc-99m pyrophosphate used for imaging studies. The dose administered is up to 25 millicuries. |
27 | $46 | $65 |
| Nuclear medicine study to assess blood loss A nuclear medicine test used to evaluate and locate active bleeding within the body. |
26 | $39 | $234 |
| Spine fracture assessment using DEXA A bone density scan that evaluates the spine for fractures. It measures bone mineral density to assess fracture risk. |
21 | $23 | $183 |
| Lymphatic system nuclear medicine study A nuclear medicine imaging test used to evaluate the structure and function of the lymphatic system. |
19 | $46 | $286 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. The procedure uses special cameras to create images of the heart's function. |
14 | $283 | $1,845 |
| Thyroid nuclear medicine study A diagnostic imaging test using radioactive material to evaluate the structure and function of the thyroid gland. |
12 | $200 | $1,415 |
| Indium in-111 labeled autologous white blood cells, diagnostic, per study dose | 11 | $1,254 | $1,596 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
51.6% medium
47.2% routine
Industry Payment Transparency
Open Payments through 2023 ↗$649
Total received (2018-2023)
Avg $130/year across 5 years
Top 33% in CA for in vivo & in vitro nuclear medicine physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
6
Companies
9
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$469 (72.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$180 (27.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2023
$15
2022
$154
2021
$80
2019
$241
2018
$159
Payments by company (2023)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$15
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Advanced Accelerator Applications
$221
Astellas Pharma US Inc
$191
Siemens Medical Solutions USA, Inc.
$126
Progenics Pharmaceuticals, Inc.
$54
Blue Earth Diagnostics Limited
$43
Boston Scientific Corporation
$15
Top 3 companies account for 82.9% of all-time payments
Associated products mentioned in payments ›
Axumin · LEXISCAN · LUTATHERA · LUTATHERA (lutetium Lu 177 dotatate) · PYLARIFY · SOMATOM Force · TheraSphere Y90 Glass Microspheres 10 GBq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (72%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
In vivo & in vitro nuclear medicine physicians within 10 mi
1
Per 100K population
0.2
County median income
$114,678
Nearest hospital
SUTTER ROSEVILLE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2023 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Vandestreek is a cardiac imaging specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Vandestreek experienced with bone density scan (dexa)?
Based on Medicare claims data, Dr. Vandestreek performed 3,706 bone density scan (dexa) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vandestreek receive payments from pharmaceutical companies?
Yes. Dr. Vandestreek received a total of $649 from 6 companies across 9 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vandestreek's costs compare to other in vivo & in vitro nuclear medicine physicians in Roseville?
Dr. Vandestreek's average Medicare payment per service is $105. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vandestreek) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
In Vivo & In Vitro Nuclear Medicine Physicians in Roseville
Browse in vivo & in vitro nuclear medicine physicians in Roseville ranked by procedure volume and transparency data.
Highest volume
Top In Vivo & In Vitro Nuclear Medicine Physicians in CA
In vivo & in vitro nuclear medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to In Vivo & In Vitro Nuclear Medicine Physicians in CA
Which CA in vivo & in vitro nuclear medicine physicians receive the most from drug and device companies.
By company
Advanced Accelerator Applications Payments to Doctors
See all physicians who received payments from Advanced Accelerator Applications.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Siemens Medical Solutions USA, Inc. Payments to Doctors
See all physicians who received payments from Siemens Medical Solutions USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology